Skip to main content
. 2022 May;11(5):738–747. doi: 10.21037/tp-22-139

Table 7. Logistic regression of effective use of glucocorticoid in SMPP.

Risk factor Standard error P value OR 95% CI
Lower limit Upper limit
Age (years) 0.047 0.402 1.045 0.752 1.103
Male 0.106 0.196 0.977 0.749 1.034
Female 0.221 0.105 1.103 0.844 1.156
LDH 0.043 0.428 1.086 1.001 1.010
MP titer 0.032 0.435 0.997 0.994 1.000
IL-18 0.121 0.006 1.398 1.103 1.773
IL-4 0.298 0.585 1.117 0.655 2.117
IFN-γ 0.096 0.011 0.783 0.650 0.946
IL-10 0.216 0.747 0.933 0.611 1.425
Fever before admission (days) 0.035 0.190 0.891 0.749 1.059
Maximum temperature before admission 0.236 0.846 1.047 0.659 1.662
Cough before admission (days) 0.089 0.592 1.018 0.951 1.092
WBC 0.051 0.200 0.936 0.847 1.036
CRP 0.015 0.426 1.012 0.983 1.041
PLT 0.002 0.061 1.005 1.000 1.009
ESR 0.018 0.490 0.988 0.954 1.023
PCT 0.530 0.406 0.280 0.014 1.062

SMPP, severe Mycoplasma pneumoniae pneumonia; MP, Mycoplasma pneumoniae; IL, interleukin; IFN-γ, interferon-γ; LDH, lactate dehydrogenase; WBC, white blood cell; CRP, C-reactive protein; PLT, platelet; ESR, Erythrocyte sedimentation rate; PCT, procalcitonin.